Social network
Our responsibility
 

Already 300 million treatments against malaria distributed in 7 years

April 25, 2014

With 300 million ASAQ Winthrop® treatments distributed and 3.6 million children reached through the program "Schoolchildren against Malaria", Sanofi confirms its commitment to the fight against the world’s most deadly parasitic disease.

Malaria caused 627,000 deaths in 20121, according to WHO, primarily on the African continent. But mortality rates have fallen 42% in 12 years as a result of actions to fight the disease, an effort in which Sanofi plays a major role.

 

Since its introduction in 2007, 300 million ASAQ Winthrop® treatments have been distributed by Sanofi in countries where the disease is endemic. Developed in partnership with DNDi (Drugs for Neglected Diseases initiative), ASAQ Winthrop® combines artesunate and amodiaquine in a fixed-dose which is in accordance with WHO recommendations. Manufactured by Sanofi in its factory in Casablanca, Morocco, ASAQ Winthrop® is now registered in 33 countries, including 30 in Africa. Its commercialization is an example of true social innovation. The anti-malarial drug is not protected by a patent and is made available to the public at under $ 1 for adults and $ 0.50 for children for three days of treatment.

 

"This is a great example of what we can achieve by adapting our strategy to solutions in which we carry no loss or profit to meet the needs of the poorest patients," said Dr. Robert Sebbag, Vice President, Sanofi Access to Medicines.


 

Aware that medication alone is not enough, Sanofi has been committed for more than a decade to a partnership strategy with African countries’ National Control Programs against Malaria to fight the disease on all fronts, including through prevention: diagnosis, access to care, training of community workers and advocacy. For example, the "Schoolchildren against Malaria" program, initiated to provide educational tools for teachers and children about the disease, has already reached more than 3.6 million children in nine African countries. As part of the initiative, the "MOSKI KIT" was developed, providing a classroom training package that enables children to learn key messages through the organization of games, skits and information on the use of insecticide-treated nets.

 

 

References:

  1. WHO, WHO Global Malaria Programme, World Malaria Report 2013